Parbendazole

CAS No. 14255-87-9

Parbendazole( SKF 29044 )

Catalog No. M20537 CAS No. 14255-87-9

Parbendazole is a potent inhibitor of microtubule assembly(EC50 : 8.79?nM).Parbendazole is a carbamate ester-amine. It finds applications in control or treatment of nematode infestations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 41 In Stock
25MG 64 In Stock
50MG 88 In Stock
100MG 155 In Stock
200MG 231 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Parbendazole
  • Note
    Research use only, not for human use.
  • Brief Description
    Parbendazole is a potent inhibitor of microtubule assembly(EC50 : 8.79?nM).Parbendazole is a carbamate ester-amine. It finds applications in control or treatment of nematode infestations.
  • Description
    Parbendazole is a potent inhibitor of microtubule assembly(EC50 : 8.79?nM).Parbendazole is a carbamate ester-amine. It finds applications in control or treatment of nematode infestations.
  • In Vitro
    Parbendazole is a tubulin destabilizer, with an EC50 of 530?nM, and can induce DNA damage. Parbendazole (2-10 μM) inhibits the assembly of microtubules dose-dependently, with an IC50 of 3 μM. Parbendazole (2-20 μM)-treated cells show an complete absence of microtubules in Vero cells. Parbendazole (up to 10 μM) inhibits the growth of CLd-AXE myxamoebae. Parbendazole (2-5 μM) potently inhibits tubulin purified from the wild-type myxamoebae.
  • In Vivo
    ——
  • Synonyms
    SKF 29044
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Microtubule/Tubulin
  • Recptor
    microtubule
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14255-87-9
  • Formula Weight
    247.29
  • Molecular Formula
    C13H17N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:4 mg/mL (16.18 mM)
  • SMILES
    CCCCc1ccc2nc(NC(=O)OC)[nH]c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lo Y C Senese S France B et al. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential[J]. Scientific Reports 2017 7(1):11261.
molnova catalog
related products
  • Auristatin F

    Auristatin F is an effective inhibitor of microtubule and vascular damaging agent. Auristatin F can be used in antibody-drug conjugates.

  • Plinabulin

    Plinabulin (NPI-2358) is a vascular disrupting agent (VDA) against tubulin-depolymerizing with IC50 of 9.8~18 nM in tumor cells. Phase 1/2.

  • Sovilnesib

    Sovilnesib is a kinesin-like protein KIF18A inhibitor (WO2020132648). Sovilnesib can be used for the research of cancer.